Channels - Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus :: FRELIP Discovery

Similar Items: Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus

Quick Look
Lipid Peroxidation and Antioxidant Status in Nonobese Type 2 Diabetes Mellitus
Quick Look
A Novel Hemizygous ANOS1 Variant in a Patient With Kallmann Syndrome and Type 2 Diabetes Mellitus: A Case Report
Quick Look
Associations between Serum Zinc Levels and the Presence of Distal Symmetric Polyneuropathy in Patients with Type 2 Diabetes Mellitus
Quick Look
Prevalence and predictors of poor glycemic control in patients with type 2 diabetes mellitus attending Alexandria Main University Hospital
Quick Look
Long‐Term Glycemic and Metabolic Profiles Observed During Imeglimin Therapy in Japanese Patients With Type 2 Diabetes Mellitus
Quick Look
Predictors of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus Referred to a Tertiary Healthcare Centre
Quick Look
Sarcopenia and sarcopenic obesity in type 2 diabetes mellitus and cardiovascular disease: current perspective and narrative review
Quick Look
The power of lifestyle intervention to induce glycaemic control in a patient with newly diagnosed type 2 diabetes and HbA1c >10%
Quick Look
Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Center, Prospective, Observational Study (REVISE Study)
Quick Look
Comment on ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Centre, Prospective, Observational Study (REVISE Study)’
Quick Look
Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes
Quick Look
Insights from maturity-onset diabetes of the young into impaired insulin secretion in type 2 diabetes
Quick Look
Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
Quick Look
Oxidative Stress‐Induced Expression Levels of PXDN and NF‐κB in Type 2 Diabetic Patients With Nephropathy
Quick Look
Circulating CXCL1 in newly diagnosed type 2 diabetes: context-dependent association with inflammatory load and metabolic indices
Quick Look
Comment on ‘Oxidative Stress‐Induced Expression Levels of PXDN and NF‐κB in Type 2 Diabetic Patients With Nephropathy’
Quick Look
Severe Osteoporosis in a Young Woman With Type 1 Diabetes and Pancreatic Exocrine Insufficiency
Quick Look
Thyroid Diseases in Omani Type 2 Diabetics: A Retrospective Cross-Sectional Study
Quick Look
Hypoglycemia Reporting in GLP‐1RA Trials for Type 1 Diabetes: A Critical Gap That Needs To Be Addressed
Quick Look
Bone Health in Type 1 Diabetes: Where We Are Now and How We Should Proceed
Quick Look
Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
Quick Look
Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters
Quick Look
The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes
Quick Look
Preliminary Outcomes of a Brief Values‐Guided Self‐Management Intervention to Improve Glucose Levels Among Emerging Adults With Type 1 Diabetes and Above‐Recommended HbA1c: A Pilot Study